Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-042826
Filing Date
2025-04-30
Accepted
2025-04-30 20:55:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 20476
2 EXHIBIT A tm2513722d1_ex-a.htm EX-99.A 13885
  Complete submission text file 0001104659-25-042826.txt   36300
Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Subject) CIK: 0001775194 (see all company filings)

EIN.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93404 | Film No.: 25898884
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address C/O ZEDRA BOOTHS HALL, BOOTHS PARK 3 CHELFORD ROAD KNUTSFORD CHESHIRE United Kingdom WA168GS
Business Address 65 CURZON STREET LONDON United Kingdom W1J 8PE 441565748800
GSR Growth Investments LP (Filed by) CIK: 0002066059 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
LEI: LP023637
Type: SCHEDULE 13G